PRCT News and Press, PROCEPT BioRobotics Corporation From 03/01/23

PROCEPT BioRobotics Corporation (PRCT) Q4 2022 Results Conference Call February 28, 2023 04:30 PM ET Company Participants Matt Bacso - Vice President-Investor Relations Reza Zadno - Chief Executive Officer Kevin Waters - Senior Vice President and Chief Financial Office...

Procept press release ( NASDAQ: PRCT ): Q4 GAAP EPS of -$0.63 misses by $0.08 . Revenue of $23.78M (+134.5% Y/Y) beats by $0.46M . U.S. system and rental revenue of $10.4 million for the fourth quarter of 2022, an increase of 109% compared to the prior year period...

REDWOOD CITY, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- PROCEPT ® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported financial results for th...

REDWOOD CITY, Calif., Feb. 13, 2023 (GLOBE NEWSWIRE) -- PROCEPT ® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that members of managem...

Summary PROCEPT BioRobotics endured a volatile start to the new year, eventually breaking above its longer-term resistance line. Market generated data is still supportive for a re-rating heading into its FY22 earnings. We retain upside targets of $55 after this analysis. Net-net...

Summary Teleflex goes into 2023 needing to prove to the Street that its 15% growth target for UroLift is still viable after multiple recent disappointments in sales growth. M&A could accelerate from here as the company has around $2B in deployable capital and a good track record of ...

REDWOOD CITY, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported preliminary unaudited revenue...

REDWOOD CITY, Calif., Dec. 14, 2022 (GLOBE NEWSWIRE) -- PROCEPT ® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that members of management will present at the up...

The following slide deck was published by PROCEPT BioRobotics Corporation in conjunction with this event. For further details see: Procept Biorobotics (PRCT) Investor Presentation - Slideshow

PROCEPT BioRobotics Corporation (PRCT) Q3 2022 Earnings Call Conference Call November 3, 2022 4:30 PM ET Company Participants Matt Bacso – Vice President-Investor Relations Reza Zadno – Chief Executive Officer Kevin Waters – Senior Vice Presi...